Fortress Biotech Inc. (FBIOP)
6.80
0.16 (2.41%)
At close: Jan 14, 2025, 3:30 PM
6.80
0.00%
After-hours Jan 14, 2025, 03:30 PM EST
undefined% (undefined)
| Bid | 6.35 |
| Market Cap | 56.88M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.863 |
| PE Ratio (ttm) | -7.88 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.58 |
| Volume | 13,799 |
| Avg. Volume (20D) | 17,939 |
| Open | 6.65 |
| Previous Close | 6.64 |
| Day's Range | 6.65 - 6.89 |
| 52-Week Range | 4.86 - 18.00 |
| Beta | undefined |
About FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 14, 2017
Employees 186
Stock Exchange NASDAQ
Ticker Symbol FBIOP
Website https://www.fortressbiotech.com
